Zatz M M, Mathieson B J, Kanellopoulos-Langevin C, Sharrow S O
J Immunol. 1981 Feb;126(2):608-13.
The AKTB-1 tumor line, previously described as having both T and B cell characteristics, was separated by electronic cell sorting (ECS) on a fluorescence-activated cell sorter (FACS) on the basis of surface immunoglobulin (sIg). This resulted in 2 distinct sIg+ and sIg- subpopulations, which were transferred in graded doses (10(1) to 10(3)) into groups of normal AKR animals. The resulting splenic tumor cells were analyzed at several time points by flow microfluorometry for surface characteristics (sIg, Thy 1, Lyt 2, and Ly9) and by erythrocyte-antibody rosetting for FcR. Two distinct sublines were identifiable--one of which was sIg+, FcR-, Thy 1.1+, Lyt 2.1+, PNA+, Ly9+ and the other of which was sIg+, FcR+, Thy 1.1-, Lyt 2.1-, PNA-, Ly 9+. When these 2 sublines, generated by ECS fractionation and high dilution transfer, were serially transferred at high doses (10(5)), they maintained their unique characteristics as distinct sublines, now designated AKTB-1t and AKTB-1b.
AKTB - 1肿瘤系先前被描述为具有T细胞和B细胞特征,通过电子细胞分选(ECS)在荧光激活细胞分选仪(FACS)上基于表面免疫球蛋白(sIg)进行分离。这产生了2个不同的sIg +和sIg -亚群,将其以分级剂量(10¹至10³)转移到正常AKR动物组中。在几个时间点通过流式微荧光测定法分析所得脾肿瘤细胞的表面特征(sIg、Thy 1、Lyt 2和Ly9),并通过红细胞 - 抗体玫瑰花结试验分析FcR。可鉴定出两个不同的亚系——其中一个是sIg +、FcR -、Thy 1.1 +、Lyt 2.1 +、PNA +、Ly9 +,另一个是sIg +、FcR +、Thy 1.1 -、Lyt 2.1 -、PNA -、Ly 9 +。当通过ECS分级分离和高稀释转移产生的这两个亚系以高剂量(10⁵)连续传代时,它们保持其作为不同亚系的独特特征,现在命名为AKTB - 1t和AKTB - 1b。